Are you an experienced scientist eager to use your scientific skills and expertise in drug discovery and preclinical research? Do you have experience from the pharma industry and a strong background in in vitro assay technologies and biomarker strategies? Are you motivated by working in a multi-disciplinary environment and take part in developing new medicines? If so, we have an exciting opportunity for you at Gubra.

About The Department

The Biomarker Assay department supports both our internal drug discovery projects, as well as our CRO business. We contribute to internal drug discovery projects through peptide binding characterization using our Octet BLI system and utilize mRNA display technology for the benefit of our early peptide discovery pipeline. For our CRO business, we deliver high-quality plasma and tissue biomarker data from in vivo pharmacology experiments. 

We are currently a team of 12 dedicated scientists and laboratory technicians who work closely together with other departments. We generate and interpret clear assay data to support preclinical research initiatives. We believe the best science happens when people support one another, share knowledge freely, and enjoy what they do. Whether it is during assay development, team-building activities, or informal gatherings, we value spending time as a team.

Primary tasks include but is not limited to:

• Participate in internal innovation processes and idea generation.
• Recommend solutions based on assay results in drug discovery projects
• Take lead in assay automatization and digitalization.
• Coordinate and support of biomarker experiments, including supervision of lab technicians.
• Analyse, interpret, review, and report study data.
• Develop new biochemical- and immunoassays and troubleshoot existing assays.

Professional qualifications:

• A background in life science, ideally at PhD level or equivalent industry experience. 
• Understanding of the drug discovery process.
• Experience with characterization of protein-ligand interactions. 
• Experience with immuno- and biomarker assays (ELISA, MSD, AlphaLISA and/or colorimetric assays).
• Background in optimization on several technical platforms.

Following qualifications will be seen as an advantage:

• Experience with the Octet BLI technology. 
• Experience in cell based in vitro/ex vivo assays. 
• Background or interest in metabolic and fibrotic diseases or neuroscience.   

As a person you:

• Are a team player, communicate proactively and share your knowledge.
• Are comfortable taking initiative within your area of expertise.
• Have strong analytical skills and enjoy scientific challenges. 
• Are an effective communicator with experience presenting scientific findings. 
• Can navigate and collaborate in an energetic and dynamic organization.
• Are curious and have a can-do attitude.

Please apply no later than May 18, 2025 by uploading your motivated cover letter and resume on our website. Please apply as soon as possible and note that applications will be reviewed on an ongoing basis. If you have questions about the position, please contact Rebecca Wendelboe Olsen, Senior Department Manager of Biomarker Assay at rwo@gubra.dk.

We look forward to receiving your application.

About Gubra

Gubra is an ambitious contract research organisation (CRO) and biotech company striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the fight for a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises. 

Gubra’s activities are focused on the early stages of drug development and are organised in two highly synergistic business areas: CRO Services and Discovery & Partnerships (D&P). We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline. 

Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market. 

People are our greatest asset, and our team consists of +270 employees all located in Hørsholm, Denmark. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!